Walking pneumonia is most often caused by a bacterium called Mycoplasma pneumoniae, which accounts for a significant share of community-acquired pneumonia cases. Unlike typical pneumonia caused by more aggressive bacteria, walking pneumonia triggers a milder infection that lets most people keep going about their day, even if they feel lousy for weeks. Several other bacteria and viruses can produce the same picture, but Mycoplasma is the dominant culprit.
Mycoplasma Pneumoniae: The Primary Cause
Mycoplasma pneumoniae is a tiny bacterium that lacks a cell wall, which makes it fundamentally different from the bacteria behind typical pneumonia. It spreads through respiratory droplets when an infected person coughs or sneezes. Once inhaled, the bacterium latches onto the cells lining your airways using a specialized structure at its tip. This attachment point contains a protein that binds directly to structural proteins on the surface of your bronchial cells, anchoring the bacterium in place so tightly that antibodies targeting this protein can reduce bacterial attachment by more than 95%.
Because Mycoplasma lacks a cell wall, it doesn’t respond to common antibiotics like penicillin or amoxicillin, which work by breaking down bacterial walls. This is one reason walking pneumonia sometimes lingers longer than people expect.
CDC data from U.S. children’s hospitals shows that Mycoplasma pneumoniae was responsible for about 11.5% of hospitalized childhood pneumonia cases overall between 2018 and 2024. But infection rates surge dramatically during outbreak years. In 2024, Mycoplasma accounted for 33% of pediatric pneumonia hospitalizations, peaking at nearly 54% in July of that year.
Other Bacteria That Cause It
Walking pneumonia falls under the broader category of “atypical pneumonia,” and a handful of other organisms can produce a similar illness. Chlamydia pneumoniae is the second most common bacterial cause, typically presenting with a sore throat, cough, and headache that can persist for weeks or even months. It can also lead to bronchitis or ear infections.
Legionella is another atypical pneumonia pathogen, but it behaves very differently. While Mycoplasma and Chlamydia infections are generally mild, Legionella can escalate quickly into severe respiratory distress, sometimes requiring mechanical ventilation. It’s also associated with gastrointestinal symptoms and electrolyte imbalances. Legionella isn’t really “walking” pneumonia in the way most people use the term, but it belongs to the same atypical family.
Less common causes include Coxiella burnetii (linked to contact with farm animals) and Francisella tularensis.
Viral Causes
Viruses can also produce the atypical pneumonia pattern that gets labeled walking pneumonia. Influenza, adenovirus, respiratory syncytial virus (RSV), coronaviruses, and cytomegalovirus have all been documented as causes. Viral walking pneumonia tends to start with upper respiratory symptoms like a runny nose or sore throat before the cough deepens. In many cases, viral atypical pneumonia resolves on its own without antibiotics, since antibiotics don’t work against viruses.
How It Spreads and Who’s at Risk
Mycoplasma pneumoniae spreads through close, prolonged contact. The incubation period is generally one to four weeks, though shorter and longer durations occur. This long incubation window means people can unknowingly spread the infection before they feel sick, which is why outbreaks cluster in places where people live, work, or study in close quarters.
Dormitories, military barracks, schools, and nursing homes are classic outbreak settings. Shared air, close sleeping arrangements, and communal dining all increase transmission. In nursing homes, the risk is compounded by the fact that older adults and medically fragile residents may not show typical symptoms like fever or cough, making infections harder to catch early. Outbreak control in these settings relies on improving ventilation (including portable air cleaners), limiting group activities, and restricting movement between units.
Children and young adults between ages 5 and 30 are the most commonly affected group, though walking pneumonia can strike at any age. People with weakened immune systems face a higher risk of developing complications.
What Happens Inside Your Lungs
Walking pneumonia affects the lungs differently than classic bacterial pneumonia. In typical pneumonia, an entire lobe of the lung fills with fluid and inflammatory cells, producing the dense white areas visible on a chest X-ray. Walking pneumonia is patchier. The infection centers on the small airways (bronchioles), causing inflammation and swelling of the bronchial walls. It then spreads outward in a lobular pattern, inflaming some clusters of air sacs while leaving neighboring ones completely untouched.
On imaging, this shows up as hazy ground-glass patches (seen in about 86% of patients on CT scans), areas of airspace consolidation (79%), and small nodules centered around the bronchioles (89%). The bronchovascular bundles, the structures that carry airways and blood vessels through the lung, appear thickened in roughly 82% of cases on CT. These scattered, patchy findings explain why walking pneumonia often looks less alarming on a chest X-ray than it feels to the patient, and why some cases are initially missed on standard X-rays but caught on CT.
Common Symptoms
Walking pneumonia earns its name because it’s mild enough that most people never take to bed. The hallmark symptom is a persistent dry cough that worsens at night and can feel relentless. Other typical symptoms include general fatigue, muscle aches, sore throat, and headache. Fever, if present, tends to be low-grade.
What distinguishes walking pneumonia from a regular cold or bronchitis is duration. The cough and malaise often drag on for two to four weeks, sometimes longer. Most cases resolve on their own without treatment, but the prolonged symptoms are what usually drive people to seek medical attention.
How It’s Diagnosed
Molecular tests that detect the bacterium’s genetic material are the preferred diagnostic method for Mycoplasma pneumoniae. These tests offer high sensitivity and specificity and return results quickly enough to guide treatment decisions. They’re typically run on a throat swab or nasal sample.
Blood tests that look for antibodies (serology) are still used in some labs but have significant drawbacks. They lack specificity and often require two separate blood draws, one during the illness and one weeks later during recovery, to confirm the diagnosis. Culturing Mycoplasma in a lab is technically possible but too slow to be practical for treatment decisions.
Treatment and Antibiotic Resistance
When walking pneumonia does require treatment, the first-line antibiotics belong to a class called macrolides. However, resistance to these drugs has become a growing global concern. In parts of Asia, macrolide resistance rates have climbed as high as 90%. In Europe and the United States, resistance remains below 10%, but it’s rising.
For resistant cases, alternative antibiotics like doxycycline are effective but come with age restrictions. Doxycycline is generally reserved for children over eight and adults. Fluoroquinolones work against resistant strains as well but carry their own side effect concerns, particularly in younger patients. For most people with walking pneumonia, though, the infection clears without any antibiotics at all.
Rare but Serious Complications
Most walking pneumonia cases are mild, but Mycoplasma pneumoniae can occasionally trigger problems outside the lungs. The bacterium is the most frequently identified infectious cause of Stevens-Johnson syndrome, a serious skin and mucous membrane reaction involving fever, eye inflammation, mouth sores, and blistering skin lesions. A related condition sometimes called Mycoplasma-induced rash and mucositis affects the mucous membranes without the typical skin blistering.
Neurological complications are rare but documented. These include inflammation of the cerebellum (causing coordination problems), acute cerebellar ataxia, opsoclonus-myoclonus syndrome (involuntary eye and muscle movements), and brain lesions affecting areas like the pons, thalamus, and basal ganglia. A handful of cases have even reported transient Parkinsonism. The prevailing theory is that these complications stem from an overactive immune response rather than the bacterium directly invading the brain.
Autoimmune hemolytic anemia, where the immune system begins attacking its own red blood cells, and kidney inflammation (glomerulonephritis) are additional rare complications linked to Mycoplasma infection.